RE: RE: Maybe a U.S. BNC poster...Beech...maybe Bushisms cascaded over all Gov't agencies during that era. Hence, maybe the USDA was worried about being potentially "fooled" by the much higher results/stats of Econiche vs Epitopix.
Hopefully this important clip of wisdom is viewable...
https://politicalhumor.about.com/od/bushvideos/youtube/bushfoolme.htm
My confidence in Econiche reaching the market and making a difference was somewhat boosted with this comment below. But then there's the wait...
"Econiche is currently going through the Australian approval process. Mr Culbert hopes it will be on the market here in about two years."
Link to article:
https://nqr.farmonline.com.au/news/nationalrural/agribusiness-and-general/general/preemptive-vaccine-against-e-coli-could-be-on-cards/2086321.aspx?storypage=0
Econiche is no longer much of a catalyst for the stock price based on valuation models from Bioniche's two firms that provide coverage. I believe the Food Safety division makes up only around 5% of the "target price" by Northland/Sandfire and 6% by Taylor Collison. But the pendulum of catalysts often swing too wide both ways so still a sensitive factor.
Econiche needs a strategic partner as mentioned many times on this board. Why not Bayer or equiv of Bayer? I guess we will have to wait till AGM to learn more. rg